Excelsyn

www.excelsyn.com

Transaction Type: Growth Capital
Status: Current Investment
Sector: Pharmaceutical and biotechnology
Investment Date: March 2007

Endless Contact: Aidan Robson

BACKGROUND

Formed by Ian Shott in 2003, Excelsyn provides a bespoke service to customers in the highly specialist area of the pharmaceutical and biotechnology sector aiming to deliver dedicated chemistry, engineering and management consulting services. The company’s highly targeted approach and agile delivery offer a unique range of solutions to enhance performance across the whole pharmaceuticals and biotechnology value chain.

Excelsyn has grown rapidly from conception, predominantly through its manufacturing and process technology facilities based in Holywell, North Wales. Excelsyn represents a great example of world-leading, technology-based businesses being developed in the UK.

INVESTMENT COMMENTARY

 
Endless acquired a minority stake in Excelsyn in March 2007 along side NorthStar Equity Investors Ltd (‘NorthStar’) who co-invested with Endless on the deal.

The combined investment underpins the company’s strategy of becoming a leading provider within the pharmaceutical supply chain. The move will give the group the resources necessary to continue its strong growth record and invest in the expansion of its manufacturing site in Holywell.

More detail on Excelsyn can be found at www.excelsyn.com and click here for the Company's press release from May 2007.

Back to Investments

Back to top